Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.1 | 0.7 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |